Treatment resistance in inclusion body myositis: the role of mast cells

Authors: Acosta, I., Hofer, M., Hilton-Jones, D., Squier, W., Brady, S.

Source: In Neuromuscular Disorders August 2024 41:20-23

MRC Centre for Neuromuscular Diseases 1st (1st December 2010), and 2nd (2nd May 2012) myotonic dystrophy workshops, London, UK and the myotonic dystrophy standards of care and national registry meeting, Newcastle, UK July 2011

Authors: Turner, C., Hilton-Jones, D., Lochmüller, H., Hanna, M.G.

Source: In Neuromuscular Disorders December 2013 23(12):1069-1080

Longitudinal observational study of sporadic inclusion body myositis: Implications for clinical trials

Authors: Cortese, A., Machado, P., Morrow, J., Dewar, L., Hiscock, A., Miller, A., Brady, S., Hilton-Jones, D., Parton, M., Hanna, M.G.

Source: In Neuromuscular Disorders May 2013 23(5):404-412

Modafinil for excessive daytime sleepiness in myotonic dystrophy type 1 – The patients’ perspective

Authors: Hilton-Jones, D., Bowler, M., Lochmueller, H., Longman, C., Petty, R., Roberts, M., Rogers, M., Turner, C., Wilcox, D.

Source: In Neuromuscular Disorders July 2012 22(7):597-603

Inclusion body myositis: MRC Centre for Neuromuscular Diseases, IBM workshop, London, 13 June 2008

Authors: Hilton-Jones, D., Miller, A., Parton, M., Holton, J., Sewry, C., Hanna, M.G.

Source: In Neuromuscular Disorders 2010 20(2):142-147

Reduction in excess daytime sleepiness by modafinil in patients with myotonic dystrophy

Authors: Talbot, K, Stradling, J, Crosby, J, Hilton-Jones, D ^∗

Source: In Neuromuscular Disorders 2003 13(5):357-364

Cardiac abnormalities and skeletal muscle weakness in carriers of Duchenne and Becker muscular dystrophies and controls

Authors: Grain, L., Cortina-Borja, M., Forfar, C., Hilton-Jones, D. ^*, Hopkin, J., Burch, M.

Source: In Neuromuscular Disorders 2001 11(2):186-191

EP.80The effects of steroid treatment on respiratory function in adults with Duchenne muscular dystrophy after loss of ambulation

Authors: Pietrusz, A., Desikan, M., Trucco, F., Manzur, A., Muntoni, F., Guglieri, M., Hilton-Jones, D., Burke, G., Hammans, S., Davies, N., Quinlivan, R.

Source: In Neuromuscular Disorders October 2019 29 Supplement 1:S176-S176

This result is not displayed to guests.
Login for full access.

NEW INSIGHTS INTO CELLULAR FUNCTIONS: O.9Dysfunctional mitophagy: a potential therapeutic target in inclusion body myositis

Authors: Brady, S., Wang, E., Carver, J., Hofer, M., Hilton, D., Hilton-Jones, D., Poulton, J., Fratter, C.

Source: In Neuromuscular Disorders October 2018 28 Supplement 2:S88-S88

This result is not displayed to guests.
Login for full access.

M02 - Low mitochondrial DNA copy number suggests abnormal mitophagy in inclusion body myositis

Authors: Brady, S., Wang, E., Carver, J., Hofer, M., Diot, A., Hilton, D., Hilton-Jones, D., Poulton, J., Fratter, C.

Source: In Neuromuscular Disorders April 2018 28 Supplement 1:S30-S30

P.359 - Different kinetic profiles of 2 patients presenting with muscle b-enolase deficiency

Authors: Wigley, R., Scalco, R., Gardiner, A., Booth, S., Chatfield, S., Godfrey, R., Desikan, M., Kirk, R., Hilton-Jones, D., Houlden, H., Quinlivan, R.

Source: In Neuromuscular Disorders October 2017 27 Supplement 2:S204-S204

Paediatric autoimmune myasthenia gravis: Any prognostic factor for disease remission?

Authors: Vecchio, D., Rodríguez Cruz, P., Hilton-Jones, D., Beeson, D., Jayawant, S., Ramdas, S., Pitt, M., DeVile, C., Robb, S., Munot, P., Palace, J.

Source: In European Journal of Paediatric Neurology June 2017 21 Supplement 1:e233-e234

M13 - Mitochondrial disease and lipid storage myopathy due to mutation in CHCHD10 or DNM1L and disordered mitochondrial dynamics

Authors: Fratter, C., Dombi, E., Carver, J., Sergeant, K., Barbosa, I.A., Hofer, M., Esiri, M., Hilton-Jones, D., Jayawant, S., Olpin, S., Deshpande, C., Simpson, M.A., Poulton, J.

Source: In Neuromuscular Disorders March 2017 27 Supplement 1:S21-S21

A.I.8 - Drug-induced myopathies in adults

Authors: Hilton-Jones, D.

Source: In Neuromuscular Disorders October 2016 26 Supplement 2:S151-S151

213th ENMC International Workshop: Outcome measures and clinical trial readiness in idiopathic inflammatory myopathies, Heemskerk, The Netherlands, 18–20 September 2015

Authors: Aggarwal, R., Allenbach, Y., Benveniste, O., De Bleecker, J.L., de Groot, I., Devilliers, H., Hilton-Jones, D., Hogrel, J.-Y., Lundberg, I.E., Mammen, A.L., Oakley, Oddis, C., Padberg, G., Ponce, D., Rider, L.G., Rose, M.R., Sanner, H., Selva- O'Callaghan, A., de Visser, M., Wells, A., Werth, V.P., Benveniste, Olivier ^*, Rider, Lisa G. ^**

Source: In Neuromuscular Disorders August 2016 26(8):523-534

Statins and myopathies

Authors: Hilton-Jones, D.

Source: In Journal of the Neurological Sciences 15 October 2015 357 Supplement 1:e476-e476

G.P.372 - Caveolinopathy presenting with muscle pain and rhabdomyolysis

Authors: Scalco, R. ^*, Gardiner, A., Pitceathly, R., Turner, C., Parton, M., Fialho, D., Hanna, M., Houlden, H., Holton, J., Manzur, A., Lucy, F., Hilton-Jones, D., Schapira, A., Murphy, E., Barresi, R., Jungbluth, H., Phadke, R., Quinlivan, R.

Source: In Neuromuscular Disorders October 2015 25 Supplement 2:S297-S297

G.P.238 - RYR1-related exertional rhabdomyolysis: Expanding spectrum and diagnostic challenges

Authors: Gardiner, A., Scalco, R. ^*, Parton, M., Hanna, M., Pitceathly, R., Zanoteli, E., Murphy, E., Treves, S., Houlden, H., Wilmshurst, J., Straub, V., Hilton-Jones, D., Voermans, N., Manzur, A., Oflazer, P., Reed, U., Lachmann, R., Quinlivan, R., Jungbluth, H.

Source: In Neuromuscular Disorders October 2015 25 Supplement 2:S257-S258